Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT05710367
Brief Summary:
The goal of this clinical trial is to test dapagliflizone in Fabry patients. The main questions it aims to answer are:
* Has 10 mg/d of dapagliflozin a positive effect on kidney functions of Fabry patients.
* Has 10 mg/d of dapagliflozin a positive effect on heart functions in Fabry patients.
Participants will be asked to
* Sign an informed consent
* Give a blood and urine samples
* Be subjected to Echocardiography investigation
* Take 10 mg/day Dapagliflizone
Researchers will compare treatment to placebo groups to see if kidneys and heart functions will be improved in the treatment group better more than the placebo group.
Study:
NCT05710367
Study Brief:
Protocol Section:
NCT05710367